Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

13.98
+0.04000.29%
Volume:13.52K
Turnover:189.03K
Market Cap:2.44B
PE:5.38
High:14.10
Open:14.10
Low:13.86
Close:13.94
52wk High:19.50
52wk Low:11.51
Shares:174.43M
Float Shares:104.00M
Volume Ratio:1.26
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.60
EPS(LYR):2.60
ROE:45.25%
ROA:-1.62%
PB:1.97
PE(LYR):5.38

Loading ...

Viz.ai announces three abstracts on Viz HCM at ACC.26

TIPRANKS
·
Yesterday

Hutchmed Initiates Phase 3 Lymphoma Treatment Trial in China

MT Newswires Live
·
Yesterday

HUTCHMED Initiates Phase III Trial in China for HMPL-760 in Relapsed/Refractory DLBCL

Stock News
·
Yesterday

Asure Software to Attend 38th Annual Roth Conference

GlobeNewswire
·
Mar 16

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

GlobeNewswire
·
Mar 16

Humanforce Launches Behaviour-Driven Recognition for Frontline Workforces

prnewswire
·
Mar 16

HUTCHMED (China) (HCM) Receives a Buy from SPDB

TIPRANKS
·
Mar 15

CICC Maintains Outperform Rating on HUTCHMED with HK$30 Target Price

Stock News
·
Mar 12

Press Release: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 12

Stock Track | HUTCHMED Soars 5.11% Intraday on Buy Rating and Hypertrophic Cardiomyopathy Treatment Developments

Stock Track
·
Mar 11

Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes

GlobeNewswire
·
Mar 11

HUTCHMED (China) (HCM) Receives a Buy from BOCOM International Holdings Company

TIPRANKS
·
Mar 11

HUTCHMED Faces Dual Setbacks: New Drug Withdrawn, Core Products Decline

Deep News
·
Mar 11

When Annual Report Meets Drug Withdrawal: Can HUTCHMED (00013) Break Its 20 Billion Valuation Stalemate?

Stock News
·
Mar 10

Hua Yuan Securities Reiterates "Buy" on HUTCHMED (00013), Sees Promise in ATTC Pipeline

Stock News
·
Mar 10

Asure Hosting Fireside Chat on Its Latest Perspective on Artificial Intelligence

GlobeNewswire
·
Mar 10

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy

GlobeNewswire
·
Mar 09

Hutchmed to Withdraw Cancer Drug in China

MT Newswires Live
·
Mar 09

HUTCHMED Commences Tazverik® Withdrawal and Product Recall

Stock News
·
Mar 09

Hutchmed discontinues all active tazemetostat clinical trials

TIPRANKS
·
Mar 09